Seeking Alpha

AbbVie - Abbott Labs (ABT -0.1%) proprietary pharmaceuticals business once the company splits in...

AbbVie - Abbott Labs (ABT -0.1%) proprietary pharmaceuticals business once the company splits in two - is selling $14.7B in one of the biggest-ever dollar-denominated debt issues in the US high-grade market. The company is offering three-year fixed-rate, three-year floating-rate, five-year, six-year, 10-year and 30-year notes in a six-part deal that is expected to price later today.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs